Blue Horseshoe Stocks: Options Ideas & More

Options Ideas

Tesla Inc. TSLA- With TSLA recently finding support after a month-long overall downtrend, and its earnings report coming up this afternoon post-market, we’re going to want to signal a few options contracts for observation.

A bullish head start yesterday may help the stock continue to run into earnings, and could turn the TSLA  Weekly $330-337.50 Calls into premium targets as we head into the end of the week.

_____

Allergan plc AGN - Despite posting a Q3 loss, AGN beat expectations, and did see an 11.4% hike in quarter-over-quarter revenues. Combined with the fact that the stock has just come off of a new 52-week low, and it makes us very interested in this as a potential recovery play.

Accordingly, we are going to put the AGN Weekly $175-180 Calls on watch for the remainder of the week, and depending on how the activity shakes out, we may want to look out to next week’s contracts if it appears a more protracted rebound is in the cards. We’ll revisit that possibility later in the week if necessary.


Apptio, Inc. APTI

We also want to provide a quick performance update on APTI, which we included in yesterday’s premarket report.

It wasn’t a blockbuster day by any means, but it did manage to rise from a low of 20.57 to as much as 24.47. That’s a 19% intraday increase, and a very respectable single-session gain for a stock that started out above $20 to begin with. It made the move on more than thirteen times the monthly average volume, so we’ll definitely let this one keep its slot on our watchlists for the time being.


Extended Watchlist:
BGFV, KNDI, BBOX, IBN, GRMN, SKLN, TNK,

Blue Horseshoe Stocks: TRXC Recap, Bottom Play & More

 TransEnterix, Inc. TRXC

We caught TRXC for a pretty nice move earlier this month, when we alerted it on the 16th, and the stock went on a two-day run from 2.15 to 4.43, scoring us a solid double-bagger.

In the weeks since then, TRXC has been under consolidation, and yesterday, we tagged it once again in our extended watchlist, and the stock produced what may be the start of another solid uptrend.

From a low of 2.50, the stock went as high as 3.03, making for a 21% rise on the day, and it maintained more than half of that move into the close on better-than-average volume.

We’ll continue to monitor for the establishment of higher highs and higher lows as TRXC attempts to get its next leg-up.


Immune Design Corp. IMDZ

We’ve got an interesting bottom setup on IMDZ, which recently took a massive downturn following the announcement of a large $80M public offering at a price of 4.10/share.

It’s also important to note that there was a huge $10M block of insider buying that came in on Friday near the lows.

Additionally, as you can see on the chart, the result of the last week of activity is a highly oversold state, and all indications seems to be pointing to the possibility of the stock regaining at least a portion of the ground it has recently lost.

Lastly, the company will be a hosting a post-market conference call tomorrow to discuss 3Q earnings and recent developments that you can tune into at http://ir.immunedesign.com/events.cfm after market close tomorrow and for 30 days thereafter.

As an added idea, we’ll radar the IMDZ 12/15 $5 Calls for observation in the days and weeks ahead. Those could see some nice activity if the stock has the recovery we suspect it might.


Extended Watchlist:
APTI, IDTI, IDRA, CGNX, MDLZ, SNE, NVAX, AMD(Bottom-Watch)